← Leaderboards
Madeline Niederkorn
St. Jude Children'S Research Hospital
$435,684
Attributed
$435,684
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $90.3K · FY2018–24$100K$75K$50K$25K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$435,684 · 3
By mechanism
K00$350,888 · 1
F99$76,402 · 1
F31$8,394 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Stephan W Morris$4,929,336
- Christine Elizabeth Canman$3,206,622
- David L. Ban$47,256
- Zhaohui Gu$1,837,199
Others in their field
Other Emerging Leaders on “Drug Discovery”
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,277,443
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- John Damon Chodera · Sloan-Kettering Inst Can Research$64,994,606
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Gary Kobinger · University Of Texas Med Br Galveston$41,631,815
Research focus
Drug DiscoveryDrug DevelopmentAllogenicDna DamageAffectBinding ProteinsBiochemicalBiologyCancer BiologyAcute Myelocytic LeukemiaCatalytic DomainCell LineCell PhysiologyCellsChromosome 5q LossChromosome AbnormalityChromosomesClone CellsComplexCurative TreatmentsCytopeniaCase StudyDisease ProgressionDruggable Target
Grant awards (7)
Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia$90,271
K00 · FY2024 · CA · contact PI
Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia$86,927
K00 · FY2023 · CA · contact PI
Regulators of ubiquitin signaling in malignant hematopoiesis$86,327
K00 · FY2022 · CA · contact PI
Regulators of ubiquitin signaling in malignant hematopoiesis$87,363
K00 · FY2021 · CA · contact PI
Regulators of ubiquitin signaling in malignant hematopoiesis$37,697
F99 · FY2019 · CA · contact PI
Regulators of ubiquitin signaling in malignant hematopoiesis$38,705
F99 · FY2018 · CA · contact PI
The TIFAB-USP15 Complex in the Pathogenesis of MDS and AML$8,394
F31 · FY2018 · HL · contact PI